NCT02568670

Brief Summary

This is a two-centers, open label, prospective, randomized, noninferiority controlled trial with cost-effectiveness analysis to verify if is non inferior to remove peripheral intravenous catheter according to clinical signs in relation to every 96 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,305

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 6, 2015

Completed
26 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

March 21, 2018

Status Verified

March 1, 2018

Enrollment Period

9 months

First QC Date

September 21, 2015

Last Update Submit

March 19, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • presence of phlebitis

    phlebitis (phlebitis/1000 peripheral venous catheters-day), stratified by severity.

    from catheter fixation, during the indwell time of the catheter, until the removal of it. For the control group, it will be up to 96 hours. From the interventional group, there is no time predict, average five or six days

Secondary Outcomes (5)

  • presence of other complications related peripheral intravenous (PIC) therapy in the two groups

    from catheter fixation, during the indwell time of the catheter, until the removal of it. For the control group, it will be up to 96 hours. From the interventional group, there is no time predict, average five or six days

  • time interval for peripheral intravenous catheter (PIC) changes

    For the control group, it will be up to 96 hours. From the interventional group, there is no time predict, average five or six days

  • total number of peripheral intravenous catheter (PIC)

    After randomization, from the first venous puncture, catheter fixation, until the removal of it, during the hospitalization. Average six days

  • Cost

    during the hospitalization, in average 5 to 6 days

  • The experience of the patient

    the questionnaire will be applied at the time of hospital discharge, hospitalization with average 6 days

Study Arms (2)

according to clinical signs

EXPERIMENTAL

removal the peripheral catheter according to clinical signs

Other: clinical signs

sistematically every 96 hours

NO INTERVENTION

removal the peripheral catheter every 96 hours

Interventions

to remove the peripheral venous catheter according clinical signs

according to clinical signs

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • with a therapeutic proposal of undergoing the therapy for at least 96 hours, or four days;
  • agree with the proposals expressed in the Informed Consent Form (ICF); and
  • have a catheter that has not been placed at the ER.
  • medical diagnosis of immunosuppression or receiving immunosuppressants;
  • using more than one peripheral catheter simultaneously;
  • refusing to take part in the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samaritano Hospital

São Paulo, São Paulo, Brazil

Location

Related Publications (1)

  • Vendramim P, Avelar AFM, Rickard CM, Pedreira MDLG. The RESPECT trial-Replacement of peripheral intravenous catheters according to clinical reasons or every 96 hours: A randomized, controlled, non-inferiority trial. Int J Nurs Stud. 2020 Jul;107:103504. doi: 10.1016/j.ijnurstu.2019.103504. Epub 2020 Jan 11.

MeSH Terms

Conditions

Phlebitis

Condition Hierarchy (Ancestors)

Peripheral Vascular DiseasesVascular DiseasesCardiovascular DiseasesVasculitis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MsC, PhD student

Study Record Dates

First Submitted

September 21, 2015

First Posted

October 6, 2015

Study Start

November 1, 2015

Primary Completion

August 1, 2016

Study Completion

September 1, 2016

Last Updated

March 21, 2018

Record last verified: 2018-03

Locations